Pharma Journalist -

Gilead Sciences, Inc. announced an agreement with Everest Medicines to transfer all development and commercialization rights to Gilead for Trodelvy (sacituzumab govitecan) in Greater…
Read More...

Merck, known as MSD outside the United States and Canada, and Orna Therapeutics, a biotechnology company pioneering a new investigational class of engineered circular RNA (oRNA)…
Read More...

Catalent, Inc. announced that it has reached an agreement to acquire Metrics Contract Services (Metrics), a full-service specialty Contract Development and Manufacturing Organization…
Read More...

Evotec SE  and Alpine Immune Sciences, Inc. announced that Evotec’s Seattle-based subsidiary, Just – Evotec Biologics, Inc., expanded a multi-year partnership with Alpine for the…
Read More...

aTyr Pharma, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted the company Fast Track designation for its lead therapeutic candidate, efzofitimod (ATYR1923),…
Read More...

TRON Group, Inc. and Nanopharmaceutics, Inc. ("Nano"), a privately-held clinical-stage pharmaceutical development company incorporated in Florida, announced today the signing of a…
Read More...

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or metastatic non-small cell lung…
Read More...

Ceapro Inc., a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced it has entered…
Read More...

Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, announced that the U.S. Food and Drug Administration (FDA) granted Orphan…
Read More...

GentiBio, Inc., an engineered regulatory T cells (Tregs) company,  announced that it has entered into a collaboration with Bristol Myers Squibb to develop new engineered Treg therapies…
Read More...